Compliance

Compliance Law360 provides cutting-edge news and analysis of interest to corporate compliance officers and the lawyers and consultants who advise them. From real-time information and data on regulation and enforcement to incisive features on the increasing demands facing chief compliance officers in today’s world, the wire aims to be a one-stop shop for CCOs looking to stay abreast with a complex world.



Sign up for a 7-day FREE trial today!



Latest News in Compliance

  • May 14, 2026

    Adani Group Chair, Nephew Ink $18M Deal To Exit SEC Case

    Indian billionaire businessman Gautam Adani and his nephew, Sagar Adani, agreed Thursday to pay a combined $18 million to resolve the U.S. Securities and Exchange Commission's suit accusing them of committing securities fraud in connection with a $750 million bond offering.

  • May 14, 2026

    Freight Brokers Brace For New Risks After High Court Ruling

    The U.S. Supreme Court on Thursday shattered what freight brokers believed was an ironclad shield against state-based negligence and injury claims over catastrophic accidents, as the trucking industry's middlemen face heightened legal exposure and question what reasonable care means in selecting motor carriers for a transport, experts say.

  • May 14, 2026

    Meta Starts NM Defense As Midtrial Win Bid Fails

    A judge denied Meta a midtrial win Thursday morning over harm to underage social media users, prompting the social media giant to call an executive to begin building a defense case that platform changes requested by New Mexico's attorney general are unnecessary or even counterproductive.

  • May 14, 2026

    NJ Doctor Prescribed Medical Marijuana To Kids, AG Says

    A New Jersey doctor had his medical license temporarily suspended by a state board, which found there is good reason to believe he is "a grave danger" to his patients after prosecutors accused him of repeatedly prescribing marijuana to adults and children without complying with state law.

  • May 14, 2026

    Takeda To Pay $13.6M Over Antidepressant Drug Kickbacks

    Takeda Pharmaceuticals will pay $13.6 million to end allegations that it caused false Medicaid claims by providing kickbacks to healthcare providers to push prescriptions of its antidepressant drug Trintellix, the U.S. Department of Justice announced Thursday.

See more Compliance news

Competition

Areas of Coverage

  • AGENCIES
  • U.S. Securities and Exchange Commission
  • U.S. Department of Justice
  • Financial Industry Regulatory Authority
  • Consumer Financial Protection Bureau
  • Office of the Comptroller of the Currency
  • Environmental Protection Agency
  • Food & Drug Administration
  • U.S. Department of Labor
  • POLICY & REGULATION
  • Financial services
  • Healthcare
  • Environmental
  • Cybersecurity
  • Employment
  • Coverage will include policy proposals and lobbying efforts
  • ENFORCEMENT
  • Actions alleging systemic breakdowns of compliance controls
  • Novel and first-of-their-kind claims
  • Compliance officer liability
  • Fraud investigations and actions
  • Insider trading
  • Money laundering
  • Enforcement actions related to corporate whistleblowers
  • PROFILES
  • Personnel moves
  • Profiles of chief compliance officers

Readership

  • Chief compliance officers at Fortune 1000 companies
  • Attorneys who advise CCOs
  • Consultants who provide compliance services to the private sector
  • Regulatory officials
  • Professors and students in law and business schools